Literature DB >> 16110168

Mast cell activation by lipoproteins.

Jim Kelley1, Gregory Hemontolor, Walid Younis, Chuanfu Li, Guha Krishnaswamy, David S Chi.   

Abstract

Mast cells are activated by a number of agents that act independently from immunoglobulin E (IgE)-mediated hypersensitivity. One of these agents is oxidized low-density lipoprotein (oxLDL). OxLDL has been implicated in the pathogenesis of atherosclerosis and has been shown to induce microvascular dysfunction by the activation of mast cells. In this chapter, we describe the method for isolation of human LDL, oxidation of LDL, and demonstrate that oxLDL activates mast cells by measuring messenger ribonucleic acid (mRNA) levels and protein levels of interleukin (IL)-8 an inflammatory cytokine. IL-8 is a potent chemoattractant for neutrophils and monocytes, which would result in a chronic inflammatory response. IL-8 mRNA levels were measured by reverse-transcription polymerase chain reaction and protein levels by enzyme-linked immunoassay.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16110168     DOI: 10.1385/1-59259-967-2:341

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

Review 1.  Mast cells in atherogenesis: actions and reactions.

Authors:  Petri T Kovanen
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

Review 2.  Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases.

Authors:  Jia-Ming Xu; Guo-Ping Shi
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

Review 3.  Do mast cells link obesity and asthma?

Authors:  N Sismanopoulos; D-A Delivanis; D Mavrommati; E Hatziagelaki; P Conti; T C Theoharides
Journal:  Allergy       Date:  2012-10-16       Impact factor: 13.146

Review 4.  Stress triggers coronary mast cells leading to cardiac events.

Authors:  Michail Alevizos; Anna Karagkouni; Smaro Panagiotidou; Magdalini Vasiadi; Theoharis C Theoharides
Journal:  Ann Allergy Asthma Immunol       Date:  2013-10-10       Impact factor: 6.347

5.  Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation.

Authors:  Martine Bot; Saskia C A de Jager; Luke MacAleese; H Maxime Lagraauw; Theo J C van Berkel; Paul H A Quax; Johan Kuiper; Ron M A Heeren; Erik A L Biessen; Ilze Bot
Journal:  J Lipid Res       Date:  2013-02-10       Impact factor: 5.922

Review 6.  Mast cells: an expanding pathophysiological role from allergy to other disorders.

Authors:  Preet Anand; Baldev Singh; Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-06       Impact factor: 3.000

7.  Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis.

Authors:  Eva Kritikou; Marie A C Depuydt; Margreet R de Vries; Kevin E Mulder; Arthur M Govaert; Marrit D Smit; Janine van Duijn; Amanda C Foks; Anouk Wezel; Harm J Smeets; Bram Slütter; Paul H A Quax; Johan Kuiper; Ilze Bot
Journal:  Cells       Date:  2019-04-09       Impact factor: 6.600

Review 8.  Functional alterations of myeloid cell subsets in hyperlipidaemia: relevance for atherosclerosis.

Authors:  Oliver Soehnlein; Maik Drechsler; Mihail Hristov; Christian Weber
Journal:  J Cell Mol Med       Date:  2009-11-09       Impact factor: 5.310

Review 9.  Mast cells in vulnerable atherosclerotic plaques--a view to a kill.

Authors:  Ken A Lindstedt; Mikko I Mäyränpää; Petri T Kovanen
Journal:  J Cell Mol Med       Date:  2007 Jul-Aug       Impact factor: 5.310

Review 10.  Mast Cell: A Multi-Functional Master Cell.

Authors:  Melissa Krystel-Whittemore; Kottarappat N Dileepan; John G Wood
Journal:  Front Immunol       Date:  2016-01-06       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.